A qualitative study of caregiver and patient perspectives on ethical and social issues in deep brain stimulation for Parkinson's disease and neuropsychiatric disorders
Renseignements sur le financement
Canadian Institutes of Health Research
- Type de subvention: Subvention de fonctionnement
- Années: 2010/11 à 2012/13
- Financement total: $241,800
- DEEP BRAIN STIMULATION
- SYSTÈME NERVEUX
- MALADIE DE PARKINSON
- METHODES QUALITATIVES
- QUALITATIVE RESEARCH
Institut de recherches cliniques de Montréal
Aucune organisation partenaire n’a été touvée.
Deep-brain stimulation (DBS) is a viable treatment for Parkinson's disease (PD) and Essential Tremor (ET) that offers advantages over drug therapy, especially for later disease stages. Since the approval of this latter technology by the FDA in 1997, over 35 000 patients in numerous countries have received deep brain stimulation with improved quality-of-life in most patients. Recent studies have expanded the use of neurostimulation. For example, in patients with treatment-resistant depression, deep brain stimulation modulating the activity of the subgenual cingulate region has improved mood. Vagus nerve stimulation (VNS) has also been tried in patients suffering from drug-resistant depression. Many important ethical and social issues arise from these neurostimulation-based surgical interventions in PD and beyond. The high costs of such procedures may create challenges for patients, providers, and healthcare systems. Securing consent for last-resort innovative interventions is another area of ethical significance given enthusiastic media response to DBS in PD. In spite of the dynamic emergence and extension of neurostimulation and related ethical and social challenges, there are few if any empirical studies identifying and characterizing the ethical and social landscape of both current and emerging practices. Of particular ethical importance is the need to understand the experience of patients and caregivers. Accordingly, this study will: 1. Identify and characterize ethical and social issues in the application of deep brain stimulation in Parkinson's disease based on patient perspectives and experiences; 2. Identify and characterize ethical and social issues in the application of deep brain stimulation in Parkinson's disease based on caregiver perspectives and experiences; 3. Identify and initiate relevant practice changes in the ethical use of deep brain stimulation in Parkinson's disease.
The neurodegenerative brain diseases - Alzheimer's Disease, Vascular dementia, Frontotemporal dementia, and Dementia with Lewy Bodies - will be the "diseases of the 21st century" due to aging of our population. The decision by CIHR to establish a Can... Plus ...
Substance misuse remains a significant global public health problem which carries a heavy burden for abusers and their families alike. This disorder is indeed associated with suffering and severe health problems in patients, distress among family mem... Plus ...
Type 1 diabetes requires that patients inject themselves insulin to control the level of sugar in their blood because their pancreas cannot do it anymore. A consequence of this treatment is low blood sugar episodes. This is named hypoglycemia. Severe... Plus ...